Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HP.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HP.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HP.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HP.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FU.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FU.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FU.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FU.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FU.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.11.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XBB.1.11.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.11.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-8626.22Germany
XBB.1.11.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.11.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
XBB.1.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
GJ.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GJ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GJ.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GJ.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GJ.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GJ.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HJ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HJ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HJ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used